FDA Grants Approval for Cyancobalamin ANDA219820 by Aspiro
The FDA has granted approval for the ANDA219820 application for Cyancobalamin submitted by Aspiro.
Therapeutic Area
Therapeutic area intelligence for Vitamin B12 with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.